替罗非班在急性心肌梗死经桡动脉冠脉介入治疗中应用的疗效和安全
例患者，结果表明，在随机分组后
[8] Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials[J]. Lancet, 2002, 359: 189-198.
[9] Warnholtz A, Ostad MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J]. Am J Cardiol 2005; 95: 20-23.
[10] Madan M, Radhakrishnan S, Reis M, et al. Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban(The ACTION Trial) [J]. Am J Cardiol 2005; 95: 1295-1301.
